Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
复制标题
DOI:
10.1159/000519491
复制
发表时间:
2021
影响因子:
4.2
通讯作者:
Johnson RJ
中科院分区:
文献类型:
--
作者:
Goldberg A;Garcia-Arroyo F;Sasai F;Rodriguez-Iturbe B;Sanchez-Lozada LG;Lanaspa MA;Johnson RJ
Hyperuricemia predicts the development of chronic kidney disease (CKD) and metabolic complications, but whether it has a causal role has been controversial. This is especially true given two recently conducted randomized controlled trials that failed to show a benefit of lowering uric acid in type 1 diabetes-associated CKD and subjects with stage 3 to 4 CKD. While these studies suggest that use of urate lowering drugs in unselected patients are unlikely to slow the progression of CKD, there are subsets of subjects with CKD where reducing uric acid synthesis may be beneficial. This may be the case in patients with gout, hyperuricemia (especially associated with increased production), and patients with urate crystalluria. Here we discuss the evidence, and propose that future clinical trials targeting these specific subgroups should be performed.
登录
查看更多内容
影响因子:
4.5
作者:
Cox CL;Stanhope KL;Schwarz JM;Graham JL;Hatcher B;Griffen SC;Bremer AA;Berglund L;McGahan JP;Keim NL;Havel PJ
通讯作者:
Havel PJ
DOI:
10.1016/j.jpeds.2012.12.078
发表时间:
2013-05
期刊:
The Journal of pediatrics
影响因子:
--
作者:
Feig DI;Madero M;Jalal DI;Sanchez-Lozada LG;Johnson RJ
通讯作者:
Johnson RJ
DOI:
10.1073/pnas.78.11.6858
发表时间:
1981-01-01
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES
影响因子:
--
作者:
AMES, BN;CATHCART, R;HOCHSTEIN, P
通讯作者:
HOCHSTEIN, P
DOI:
10.2215/cjn.03140315
发表时间:
2015-11-01
影响因子:
9.8
作者:
De Cosmo, Salvatore;Viazzi, Francesca;Pontremoli, Roberto
通讯作者:
Pontremoli, Roberto
影响因子:
2.5
作者:
Gondouin, Bertrand;Jourde-Chiche, Noemie;Dussol, Bertrand
通讯作者:
Dussol, Bertrand